Skip to main content

Table 5 Treatment outcomes of tuberculosis patients diagnosed through mobile team activity in four regions and three states, Myanmar, October 2014-December 2014

From: Active case-finding for tuberculosis by mobile teams in Myanmar: yield and treatment outcomes

Variable

Total patients n (%)

Initial lossa n

Treatment success1 n (%)

Failed n (%)

Died n (%)

LTFU2 n (%)

Not evaluated n (%)

Moved to SLD3 n (%)

All TB patients

504

20 (4.0)

438 (90.5)

7 (1.4)

13 (2.7)

13 (2.7)

9 (1.9)

4 (0.8)

New & Relapse

501

20 (4.0)

437 (90.5)

7 (1.5)

13 (2.7)

12 (2.5)

9 (1.9)

3 (0.6)

NSP PTB4

85

1 (1.2)

78 (91.8)

2 (2.4)

2 (2.4)

1 (1.2)

1 (1.2)

0 (0.0)

TB type

 SSP PTB5

108

2 (1.9)

93 (87.7)

4 (3.8)

3 (2.8)

2 (1.9)

1 (0.9)

3 (2.8)

 SSN PTB6

393

18 (4.6)

342 (91.2)

3 (0.8)

10 (2.7)

11 (2.9)

8 (2.1)

1 (0.3)

 EPTB7

3

0

3 (100)

     

TB category

 New

448

17 (3.8)

401 (93.0)

4 (0.9)

10 (2.3)

10 (2.3)

6 (1.4)

0 (0.0)

 Retreatment

56

3 (5.4)

37(66.0)

3 (6.3)

3 (6.3)

3 (6.3)

3 (6.3)

4 (7.1)

 Relapse

53

3 (5.4)

36 (72.0)

3 (6.0)

3 (6.0)

2 (4.0)

3 (6.0)

3 (6.0)

 LTFU2

3

0

1 (33.3)

0 (0.0)

0 (0.0)

1 (33.3)

0 (0.0)

1 (33.3)

Treatment

 IR8

416

15 (3.6)

371 (92.5)

4 (1.0)

10 (2.5)

10 (2.5)

6 (1.5)

0 (0.0)

 RR9

56

3 (5.4)

37 (69.8)

3 (5.7)

3 (5.7)

3 (5.7)

3 (5.7)

4 (7.5)

 CR10

32

2 (6.3)

30(100)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

  1. 1Treatment Success includes patients who are cured and completed treatment
  2. 2LTFU: Loss-to-follow up; 3SLD: Second line drugs; 4NSP PTB: New smear positive PTB
  3. 5SSP PTB: Sputum smear positive Pulmonary TB 6 SSN PTB: Sputum smear negative Pulmonary TB; 7EPTB: Extra pulmonary TB 8IR: Initial Regimen 9RR: Retreatment Regimen 10CR: Childhood Regimen
  4. aThis is calculated on total TB patients diagnosed while other outcomes excluding initial loss from the denominators